Avalyn Pharmaceuticals
Develops improved therapies for idiopathic pulmonary fibrosis (IPF) and other respiratory diseases.
Develops improved therapies for idiopathic pulmonary fibrosis (IPF) and other respiratory diseases.
Sector
Life SciencesCategory
TherapeuticsLocation
Seattle, WAInitial Investment
2017
Avalyn is a biopharma company committed to developing improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases.